Skip to main content

Peer Review reports

From: PROPERTY: study protocol for a randomized, double-blind, multicenter placebo-controlled trial assessing neurotoxicity in patients with metastatic gastrointestinal cancer taking PHYCOCARE® during oxaliplatin-based chemotherapy

Original Submission
24 Dec 2021 Submitted Original manuscript
10 May 2022 Reviewed Reviewer Report - Kirsty Loudon
19 Oct 2022 Reviewed Reviewer Report - Guang Ji
25 Oct 2022 Reviewed Reviewer Report - Anastasia Karachalia-Sandri Karachalia-Sandri
3 Dec 2022 Author responded Author comments - Christele Le Gouill-Jaijarat
Resubmission - Version 2
3 Dec 2022 Submitted Manuscript version 2
5 Dec 2022 Reviewed Reviewer Report - Guang Ji
5 Dec 2022 Reviewed Reviewer Report - Kirsty Loudon
11 Dec 2022 Reviewed Reviewer Report - Anastasia Karachalia-Sandri Karachalia-Sandri
22 Dec 2022 Author responded Author comments - Christele Le Gouill-Jaijarat
Resubmission - Version 3
22 Dec 2022 Submitted Manuscript version 3
23 Dec 2022 Reviewed Reviewer Report - Kirsty Loudon
2 Jan 2023 Reviewed Reviewer Report - Anastasia Karachalia-Sandri Karachalia-Sandri
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
5 Jan 2023 Editorially accepted
20 Jan 2023 Article published 10.1186/s13063-023-07071-z

You can find further information about peer review here.

Back to article page